Interferon Alfa-2A vs Ipilimumab
Interferon Alfa-2A vs Ipilimumab: Overview
This comparison examines the pharmacological differences between Interferon Alfa-2A and Ipilimumab.
Mechanism of Action
Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.
Pharmacokinetics
Half-life: Ipilimumab — 14.7 days.
Chemical Properties
Type: Interferon Alfa-2A — Protein; Ipilimumab — Antibody.